Microbiome in Head and Neck Squamous Cell Carcinoma

RecruitingOBSERVATIONAL
Enrollment

60

Participants

Timeline

Start Date

December 31, 2025

Primary Completion Date

January 31, 2028

Study Completion Date

January 31, 2030

Conditions
Head and Neck CancerLip CancerOral CancerPharynx Cancer
Interventions
DIAGNOSTIC_TEST

Metagenomic sequencing

Shotgun metagenomic sequencing will characterize cancer-associated changes in microbial functional capacity and species/strain-level taxonomic profiles. Metagenomics will provide data on microbial functional capacity along with broader taxonomic classifications.

DIAGNOSTIC_TEST

Metabolic analysis

Metabolic analysis will be conducted using LC/MS-based metabolic analysis. A targeted approach will quantify a panel of 30 compounds including Trp pathway products while a non-targeted approach, when applied to both lipid and aqueous phase compounds, will profile relative changes in compounds that may influence host

Trial Locations (1)

80045

RECRUITING

University of Colorado Cancer Center, Aurora

All Listed Sponsors
collaborator

National Cancer Institute (NCI)

NIH

lead

University of Colorado, Denver

OTHER